| An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical … HK Reddel, DR Taylor, ED Bateman, LP Boulet, HA Boushey, WW Busse, ... American journal of respiratory and critical care medicine 180 (1), 59-99, 2009 | 2139 | 2009 |
| Long-term inhaled corticosteroids in preschool children at high risk for asthma TW Guilbert, WJ Morgan, RS Zeiger, DT Mauger, SJ Boehmer, SJ Szefler, ... New England Journal of Medicine 354 (19), 1985-1997, 2006 | 1461 | 2006 |
| Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids SE Wenzel, SJ Szefler, DYM Leung, SI Sloan, MD Rex, RJ Martin American journal of respiratory and critical care medicine 156 (3), 737-743, 1997 | 1091 | 1997 |
| A summary of the new GINA strategy: a roadmap to asthma control HK Reddel, ED Bateman, A Becker, LP Boulet, AA Cruz, JM Drazen, ... European Respiratory Journal 46 (3), 622-639, 2015 | 1001 | 2015 |
| Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children WW Busse, WJ Morgan, PJ Gergen, HE Mitchell, JE Gern, AH Liu, ... New England Journal of Medicine 364 (11), 1005-1015, 2011 | 969 | 2011 |
| International consensus on (ICON) pediatric asthma NG Papadopoulos, H Arakawa, KH Carlsen, A Custovic, J Gern, ... Allergy 67 (8), 976-997, 2012 | 867 | 2012 |
| COVID-19 and the impact of social determinants of health EM Abrams, SJ Szefler The Lancet Respiratory Medicine 8 (7), 659-661, 2020 | 753 | 2020 |
| Significant variability in response to inhaled corticosteroids for persistent asthma SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ... Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002 | 738 | 2002 |
| Characterization of within-subject responses to fluticasone and montelukast in childhood asthma SJ Szefler, BR Phillips, FD Martinez, VM Chinchilli, RF Lemanske Jr, ... Journal of Allergy and Clinical Immunology 115 (2), 233-242, 2005 | 736 | 2005 |
| Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ... The Lancet 364 (9444), 1505-1512, 2004 | 736 | 2004 |
| A new perspective on concepts of asthma severity and control DR Taylor, ED Bateman, LP Boulet, HA Boushey, WW Busse, TB Casale, ... European Respiratory Journal 32 (3), 545-554, 2008 | 734 | 2008 |
| Tiotropium bromide step-up therapy for adults with uncontrolled asthma SP Peters, SJ Kunselman, N Icitovic, WC Moore, R Pascual, BT Ameredes, ... New England Journal of Medicine 363 (18), 1715-1726, 2010 | 714 | 2010 |
| The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ... American journal of respiratory and critical care medicine 162 (1), 75-80, 2000 | 697 | 2000 |
| Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma TW Guilbert, WJ Morgan, RS Zeiger, LB Bacharier, SJ Boehmer, ... Journal of Allergy and Clinical Immunology 114 (6), 1282-1287, 2004 | 593 | 2004 |
| Patterns of growth and decline in lung function in persistent childhood asthma MJ McGeachie, KP Yates, X Zhou, F Guo, AL Sternberg, ML Van Natta, ... New England Journal of Medicine 374 (19), 1842-1852, 2016 | 589 | 2016 |
| Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β DYM Leung, Q Hamid, A Vottero, SJ Szefler, W Surs, E Minshall, ... The Journal of experimental medicine 186 (9), 1567-1574, 1997 | 586 | 1997 |
| Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. JC Kam, SJ Szefler, W Surs, ER Sher, DY Leung Journal of immunology (Baltimore, Md.: 1950) 151 (7), 3460-3466, 1993 | 583 | 1993 |
| Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial SJ Szefler, H Mitchell, CA Sorkness, PJ Gergen, G T O'Connor, ... The Lancet 372 (9643), 1065-1072, 2008 | 582 | 2008 |
| Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations SJ Teach, MA Gill, A Togias, CA Sorkness, SJ Arbes Jr, A Calatroni, ... Journal of Allergy and Clinical Immunology 136 (6), 1476-1485, 2015 | 550 | 2015 |
| Daily versus as-needed corticosteroids for mild persistent asthma HA Boushey, CA Sorkness, TS King, SD Sullivan, JV Fahy, SC Lazarus, ... New England Journal of Medicine 352 (15), 1519-1528, 2005 | 543 | 2005 |
